3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
27
Neoplasm Metastasis
9
Stomach Neoplasms
7
Ovarian Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Esophageal Neoplasms
3
Endometrial Neoplasms
3
Sarcoma
2
Salivary Gland Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Melanoma
2
HER2-positive Gastric Cancer
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Advanced Solid Tumor
2
Advanced Breast Cancer
2
Adenocarcinoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Unresectable Locally Recurrent Breast Cancer
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Interventions
Capecitabine
29
Oxaliplatin
28
Fluorouracil
16
Radiotherapy
15
Drug Therapy
11
Leucovorin
10
Bevacizumab
10
Surgical Procedures, Operative
9
Chemoradiotherapy
8
Radiation
7
sintilimab
6
Consolidation Chemotherapy
6
tislelizumab
5
spartalizumab
5
Specimen Handling
5
Irinotecan
5
Folfox protocol
5
trifluridine tipiracil drug combination
4
XELOX
4
Neoadjuvant Therapy
4
Endoscopy
4
Cetuximab
4
Biopsy
4
toripalimab
3
pembrolizumab
3
irinotecan sucrosofate
3
X-Rays
3
Radiotherapy, Intensity-Modulated
3
Proctectomy
3
Mastectomy, Segmental
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Rectal Neoplasms
×
trastuzumab deruxtecan
×
Clear all
NCT07407465
2026-02-17
CHIMERA
Gruppo Oncologico del Nord-Ovest
Phase 2
Recruiting
42 enrolled